As the use of psychedelic substances increases in popularity around the globe, so does the potential for both harms and benefits. Some suggest that the speed of pharmaceutical and policy development is outpacing our understanding of how to effectively protect patients and consumers, while others argue that the best way to reduce potential harms is to legalize and regulate psychedelics, as is currently taking place in a number of jurisdictions in the US and around the globe.
Prompted by a recent NYT guest essay by Jules Evans, this friendly debate exploring the safest next steps for psychedelics will feature Philippe Lucas, PhD, a Research Affiliate with the Michigan Psychedelic Center and co-Principal Investigator of the Global Psychedelic Survey 2023/25 and Jules Evans, Director of the Challenging Experiences Project. Please join the conversation on June 10th at 10am PDT (1pm EDT / 6pm GMT+1) on Zoom as Philippe and Jules explore different pathways to safe, legal access to psychedelics.
